Group items tagged

The global breast cancer drug market size is expected to reach USD 38.4 billion by 2025. It is projected to expand at a CAGR of 10.7% during the forecast period. Early detection, increase in awareness, and incidence of breast cancer are some of the key trends stoking market growth. Global breast cancer drugs market is expected to grow lucratively as many players focus majorly on R&D of innovative treatments. They engage in extensive research to develop novel drugs for the treatment of the disease to gain a higher market share. There exists a growing pressure and need for novel therapies and treatment due to rapidly accelerating prevalence of diseases. The strong pipeline is expected to provide new and effective treatment options and improved outcomes than existing therapies. With advancements in drug delivery systems, various target specific therapies have been customized and designed as a carrier to infuse the therapeutic agent to the target site. Carriers for inducing target therapy include modified anticancer agent's specific to molecular-recognition-element, anticancer peptides, and nanoparticle-based anticancer drugs. For instance, HER2/neu protein is usually given in combination with other anti-cancer drugs in targeted therapy. Get Free Sample Copy of this Report at at: https://www.radiantinsights.com/research/breast-cancer-drugs-market/request-sample F. Hoffman-La Roche Ltd leads the breast cancer drugs market with Herceptin, Perjeta, and Kadcyla. However, rapid advancements in biosimilars with a goal to offer cost effective alternatives to patients is anticipated to put pressure on this space. For instance, in December 2017, the Food and Drug Administration (FDA) approved the first biosimilar of trastuzumab for HER2+ breast cancer. Further key findings from the report suggest: * HER2 inhibitors is expected to be the most preferred drug class segment over the forecast period, owing to their high specificity as they are subclass of target therapy *

"Breast Cancer Drugs Market Breast Cancer Drugs Industry Breast Cancer Drugs Cancer drugs"

"Drug metabolism is the metabolic breakdown of drugs by living organisms, usually through specialized enzymatic systems. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Metabolism Drugs Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China)."

Pharma14 provides the biggest pharma medicine or drug database with a range of information to help you with medicine or drug price database. One of the modules is the finished dosages ready for licensing.

In this session the instructor will discuss about the pediatric drug development study and the regulations that support this initiative.

"The global pharmacovigilance market size is expected to reach USD 11.64 billion by 2026. It is projected to expand at a CAGR of 13.3% during the forecast period. Increasing incidence of Adverse Drug Reactions (ADR) is the key growth driver. The U.S. Food and Drug Administration (FDA) received approximately 253,017 serious adverse events and 44,693 deaths associated with ADRs in 2015. This shows the potential demand for implementing safety and Pharmacovigilance (PV) services."

"global aromatherapy market size is anticipated to reach USD 2.8 billion by 2026, expanding at a CAGR of 10.4% during the forecast period. This growth can be attributed to the increased awareness about the therapeutic benefits of essential oils. Aromatherapy is expected to play a significant role in the field of alternative medicines with a gradual shift from man-made drugs to essential oils to gain therapeutic values. On the basis of a 2016 article by the National Center for Biotechnology Information (NCBI), a clinical trial was conducted on 50 patients suffering from second- and third-degree burns, to study the effects of inhaling these products. The result showed that the products were significantly effective in reducing pain arising from such wounds. Hence, aromatherapy can be used as a complementary therapy for pain relief amongst burn patients, thereby, supporting the market growth. Some of the other therapeutic applications include issues related to skin, digestion, respiratory disorders, insomnia, and immune system functioning. Essential oils also possess many factors that make them naturally healing solutions. Therapeutic grade essential oils positively impact the overall wellness of the patient. These products have the potential to be natural cleansers and an antibacterial remedy when ingested. People are also becoming aware of the benefits offered by natural therapies as they support the body's innate healing abilities. With experience and education, they are realizing that bacteria and viruses do not develop resistance to natural substances, the way they do in case of synthetic drugs."

New professional article at Farmavita.Net

Sonophoresis is defined as the application of ultrasound to the skin resulting in enhanced transdermal transport of molecules.

Learn about various product approval processes, product development and regulatory filing strategies focusing on 505(b)(2) pathway.